Tonix Pharmaceuticals Holding Corp
NASDAQ:TNXP
Tonix Pharmaceuticals Holding Corp
NASDAQ:TNXP
Price:
14.19
USD
1.79%
Market Cap:
$181.5m
Balance Sheet
Balance Sheet Decomposition
Tonix Pharmaceuticals Holding Corp
Tonix Pharmaceuticals Holding Corp
Balance Sheet Decomposition is not available for
Tonix Pharmaceuticals Holding Corp
Tonix Pharmaceuticals Holding Corp
Balance Sheet
Tonix Pharmaceuticals Holding Corp
Tonix Pharmaceuticals Holding Corp
Currency: USD
| Dec-2007 | Dec-2008 | Dec-2009 | Dec-2010 | Dec-2011 | Dec-2012 | Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||||||||
| Cash & Cash Equivalents |
0
|
0
|
0
|
0
|
0
|
2
|
8
|
38
|
19
|
19
|
26
|
25
|
11
|
77
|
179
|
120
|
25
|
99
|
|
| Cash Equivalents |
0
|
0
|
0
|
0
|
0
|
2
|
8
|
38
|
19
|
19
|
26
|
25
|
11
|
77
|
179
|
120
|
25
|
99
|
|
| Short-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
24
|
7
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
5
|
|
| Accounts Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
4
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
|
| Inventory |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
14
|
8
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
3
|
1
|
1
|
1
|
3
|
11
|
10
|
11
|
9
|
7
|
|
| Total Current Assets |
0
|
0
|
0
|
0
|
0
|
2
|
9
|
39
|
46
|
27
|
26
|
26
|
14
|
88
|
189
|
131
|
48
|
119
|
|
| PP&E Net |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
10
|
52
|
95
|
95
|
43
|
|
| PP&E Gross |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
10
|
52
|
95
|
95
|
43
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
84
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
5
|
4
|
|
| Intangible Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
10
|
0
|
|
| Goodwill |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
|
| Other Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
|
| Total Assets |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
+100%
|
2
+425%
|
9
+314%
|
40
+354%
|
47
+19%
|
28
-41%
|
27
-3%
|
26
-2%
|
15
-44%
|
98
+573%
|
241
+145%
|
226
-6%
|
154
-32%
|
163
+5%
|
|
| Liabilities | |||||||||||||||||||
| Accounts Payable |
0
|
0
|
0
|
0
|
1
|
1
|
1
|
2
|
3
|
1
|
1
|
1
|
3
|
5
|
13
|
8
|
4
|
5
|
|
| Accrued Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
2
|
4
|
1
|
0
|
1
|
1
|
3
|
5
|
6
|
5
|
11
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
3
|
|
| Other Current Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
3
|
4
|
4
|
7
|
0
|
|
| Total Current Liabilities |
0
|
0
|
0
|
0
|
1
|
1
|
2
|
3
|
7
|
2
|
2
|
3
|
5
|
10
|
22
|
18
|
19
|
18
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
2
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
7
|
5
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
0
|
23
|
0
|
|
| Total Liabilities |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
3
+625%
|
1
-59%
|
2
+83%
|
4
+59%
|
7
+94%
|
2
-69%
|
2
N/A
|
3
+29%
|
5
+89%
|
11
+106%
|
22
+111%
|
19
-17%
|
49
+164%
|
23
-52%
|
|
| Equity | |||||||||||||||||||
| Common Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
|
| Retained Earnings |
0
|
0
|
0
|
3
|
6
|
16
|
27
|
54
|
102
|
141
|
162
|
189
|
217
|
268
|
360
|
470
|
601
|
731
|
|
| Additional Paid In Capital |
0
|
0
|
0
|
3
|
4
|
17
|
33
|
90
|
143
|
167
|
187
|
212
|
227
|
355
|
578
|
677
|
706
|
871
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
3
-1 150%
|
1
N/A
|
7
+550%
|
36
+455%
|
40
+12%
|
25
-37%
|
25
-3%
|
24
-4%
|
9
-60%
|
88
+832%
|
219
+150%
|
207
-5%
|
106
-49%
|
140
+32%
|
|
| Total Liabilities & Equity |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
+100%
|
2
+425%
|
9
+314%
|
40
+354%
|
47
+19%
|
28
-41%
|
27
-3%
|
26
-2%
|
15
-44%
|
98
+573%
|
241
+145%
|
226
-6%
|
154
-32%
|
163
+5%
|
|
| Shares Outstanding | |||||||||||||||||||
| Common Shares Outstanding |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
4
|
|
Switch to:
Switch to:
See Also
Discover More
